擅長領(lǐng)域：腫瘤各?？剖中g(shù)的麻醉及危重病人的處理?

執(zhí)業(yè)經(jīng)歷： 2001年中山醫(yī)科大學(xué)本科畢業(yè)后一直在中山大學(xué)腫瘤防治中心麻醉科工作，2005年獲中山大學(xué)臨床醫(yī)學(xué)碩士學(xué)位，2010年獲中山大學(xué)臨床醫(yī)學(xué)博士學(xué)位，2012年起受聘副主任醫(yī)師。2010年2月-2011年1月赴美國Thomas Jefferson University進(jìn)修學(xué)習(xí)，開展與參與多項(xiàng)基礎(chǔ)及臨床研究，主要從事麻醉藥物作用機(jī)制及其與惡性腫瘤發(fā)生、發(fā)展和轉(zhuǎn)移關(guān)系以及單肺通氣肺損傷的研究。目前承擔(dān)國家自然青年基金一項(xiàng)。 　　代表論文： 　　1. Cao L, Young N, Liu H, Silvestry S, Sun W, Zhao N, Diehl J, Sun J. Preoperative Aspirin Use and Outcomes in Cardiac Surgery Patients. Ann Surg 2012;255(2)：399-404. (IF：6.329) 　　2. Cao L, Silvestry S, Zhao N, Diehl J, Sun J. Effects of preoperative aspirin on cardiocerebral and renal complications in non-emergent cardiac surgery patients: a sub-group and cohort study. PLoS One 2012;7(2)：e30094. (IF：3.730) 　　3. Cao L, Chang Y, Lin W, Zhou J, Tan H, Yuan Y, Zeng W. Long-term Survival after resection of hepatocellular carcinoma: A potential risk associated with the choice of postoperative analgesia. Anesth Analg. 2014 Jun; 118(6):1309-16. (IF：3. 30) 　　4. Zhou JH, Cao LH, et al.Contrast-enhanced gray-scale ultrasound for quantitative evaluation of tumor response to chemotherapy: preliminary results with a mouse hepatoma model. AJR Am J Roentgenol 2011;196 (1)：W13-W17. (IF：2.897)(co-first authors) 　　5. Lin CY, Cao LH, et al. Ultrasonic spectrum analysis for in vivo characterization of tumor microstructural changes in the evaluation of tumor response to chemotherapy using diagnostic ultrasound.. BMC Cancer 2013;13:302. (IF：3.33). (co-first authors) 　　6. Sun JZ, Cao LH, et al.ACE inhibitors in cardiac surgery: current studies and controversies. Hypertens Res 2011; 34(1):15-22. (IF: 2.426) 　　7. Zhou JH, Cao LH, et al. Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US. Radiology; 2011;259(2):406-13 (IF: 6.339) 　　8. Zhou JH, Zheng W, Cao LH, et al. Quantitative evaluation of viable tissue perfusion changes with contrast-enhanced greyscale ultrasound in a mouse hepatoma model following treatment with different doses of thalidomide. Br J Radiol 2011;84(1005):826-32 (IF: 1.217) 　　9. Zhou JH, Zheng W, Cao LH, et al. Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment. Eur J Radiol 2011 Feb 21. (IF：2.941) 　　10. Zhou JH, Zheng W, Cao LH, et al. Antiangiogenic tumor treatment noninvasive monitoring with contrast pulse sequence imaging for contrast-enhanced grayscale ultrasound. Acad Radiol 2010; 17(5):646-651. (IF: 2.195) 　　11. Zhou JH, Li AH, Cao LH, et al. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: the assessment using contrast-enhanced ultrasound. Br J Radiol 2008; 81(2):113-119. (IF: 2.062) 　　12. Wu SY, Ling Q, Cao LH, et al.Real-time two-dimensional ultrasound guidance for central venous cannulation.:a meta-analysis. Anesthesiology;2013,118(2) (IF：5.163) 　　13. Wang JW, Zheng W, Chen Y, Cao LH, Luo RZ, Li AH, Zhou JH. Quantitative assessment of tumor blood flow changes in a murine breast cancer model after adriamycin chemotherapy using contrast-enhanced destruction-replenishment sonography. J Ultrasound Med. 2013; 32(4):683-90. (IF：1.402) 　　14. Wang JW, Zheng W, Liu JB, Chen Y, Cao LH, Luo RZ, Li AH, Zhou JH. Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts. PLoS One 2013; 8(3):e58274.( IF：3.73) 詳細(xì)介紹